Large-scale testing (Phase 3)Active Not RecruitingNCT03432286
What this trial is testing
Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Who this might be right for
Episodic Migraine
Eli Lilly and Company 533
Showing 20 of 87 results